login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
ETON PHARMACEUTICALS INC (ETON) Stock News
USA
- NASDAQ:ETON -
US29772L1089
-
Common Stock
20.28
USD
-0.65 (-3.11%)
Last: 10/9/2025, 5:09:41 PM
20
USD
-0.28 (-1.38%)
After Hours:
10/9/2025, 5:09:41 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
ETON Latest News, Press Relases and Analysis
All
Press Releases
2 months ago - By: Eton Pharmaceuticals
Eton Pharmaceuticals to Participate at 2025 Wells Fargo Healthcare Conference
2 months ago - By: Zacks Investment Research
- Mentions:
ADCT
Eton Pharmaceuticals, Inc. (ETON) Reports Q2 Loss, Tops Revenue Estimates
2 months ago - By: The Motley Fool
Eton (ETON) Q2 Revenue Jumps 108%
2 months ago - By: Eton Pharmaceuticals
Eton Pharmaceuticals Reports Second Quarter 2025 Financial Results
2 months ago - By: Benzinga
- Mentions:
GSAT
PGY
ADV
REAL
...
Earnings Scheduled For August 7, 2025
2 months ago - By: Eton Pharmaceuticals
Eton Pharmaceuticals to Report Second Quarter 2025 Financial Results on Thursday, August 7, 2025
5 months ago - By: Benzinga
A Glimpse Into The Expert Outlook On Eton Pharmaceuticals Through 4 Analysts
3 months ago - By: Eton Pharmaceuticals
Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-600 (Desmopressin Oral Solution)
3 months ago - By: Eton Pharmaceuticals
Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-600 (Desmopressin Oral Solution)
3 months ago - By: Eton Pharmaceuticals
Eton Pharmaceuticals Announces Addition to Russell 2000® and Russell 3000® Indexes
3 months ago - By: Eton Pharmaceuticals
Eton Pharmaceuticals Announces Addition to Russell 2000® and Russell 3000® Indexes
4 months ago - By: Zacks Investment Research
Eton Pharmaceuticals (ETON) Upgraded to Buy: Here's Why
4 months ago - By: Zacks Investment Research
Eton Pharmaceuticals (ETON) Is a Great Choice for 'Trend' Investors, Here's Why
4 months ago - By: Eton Pharmaceuticals
Eton Pharmaceuticals Announces U.S. FDA Approval for KHINDIVI™ (hydrocortisone) Oral Solution
4 months ago - By: Eton Pharmaceuticals
Eton Pharmaceuticals Announces U.S. FDA Approval for KHINDIVI™ (hydrocortisone) Oral Solution
5 months ago - By: Eton Pharmaceuticals
Eton Pharmaceuticals to Participate at Upcoming Investor Conferences
5 months ago - By: Eton Pharmaceuticals
Eton Pharmaceuticals Reports First Quarter 2025 Financial Results
5 months ago - By: Eton Pharmaceuticals
Eton Pharmaceuticals Reports First Quarter 2025 Financial Results
5 months ago - By: Zacks Investment Research
- Mentions:
TELA
TELA Bio, Inc. (TELA) Reports Q1 Loss, Tops Revenue Estimates
5 months ago - By: Zacks Investment Research
- Mentions:
MRUS
Earnings Preview: Merus N.V. (MRUS) Q1 Earnings Expected to Decline
5 months ago - By: Eton Pharmaceuticals
Eton Pharmaceuticals to Report First Quarter 2025 Financial Results on Tuesday, May 13, 2025
5 months ago - By: Eton Pharmaceuticals
Eton Pharmaceuticals to Report First Quarter 2025 Financial Results on Tuesday, May 13, 2025
5 months ago - By: Zacks Investment Research
- Mentions:
TRDA
Eton Pharmaceuticals, Inc. (ETON) Earnings Expected to Grow: What to Know Ahead of Q1 Release
5 months ago - By: Eton Pharmaceuticals
Eton Pharmaceuticals Announces Submission of NDA for ET-600 (Desmopressin Oral Solution)
5 months ago - By: Eton Pharmaceuticals
Eton Pharmaceuticals Announces Submission of NDA for ET-600 (Desmopressin Oral Solution)
6 months ago - By: Eton Pharmaceuticals
Eton Pharmaceuticals Out-Licenses International Rights to Increlex®
6 months ago - By: Eton Pharmaceuticals
Eton Pharmaceuticals Out-Licenses International Rights to Increlex®
7 months ago - By: Eton Pharmaceuticals
Eton Pharmaceuticals Reports Fourth Quarter 2024 Financial Results
7 months ago - By: Eton Pharmaceuticals
Eton Pharmaceuticals Reports Fourth Quarter 2024 Financial Results
7 months ago - By: Eton Pharmaceuticals
Eton Pharmaceuticals Announces Positive Pivotal Clinical Study Results for Product Candidate ET-600
7 months ago - By: Eton Pharmaceuticals
Eton Pharmaceuticals Announces Positive Pivotal Clinical Study Results for Product Candidate ET-600
Please enable JavaScript to continue using this application.